Three independent discounted-cash-flow-style models value Utah Medical Products Inc every trading day. 0 of 3 currently price UTMD above its market price.
| Free Cash Flow model | $71.12 |
| Excess Profit model | $62.84 |
| Residual Earnings model | $43.63 |
| Dividend Discount model | $32.13 |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +7.6% |
| Net debt / EBITDA | -7.5× |
| Gross margin | +57.1% |
| Revenue CAGR | -9.7% |
| Cash conversion | 1.3× |
| Dividend yield | +1.7% |
| Buyback yield | +7.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open UTMD in StockKitty